181 related articles for article (PubMed ID: 6872005)
1. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells.
Schlager SI; Meltzer MS
Cell Immunol; 1983 Aug; 80(1):10-9. PubMed ID: 6872005
[TBL] [Abstract][Full Text] [Related]
2. Role of macrophage lipids in regulating tumoricidal activity.
Schlager SI; Madden LD; Meltzer MS; Bara S; Mamula MJ
Cell Immunol; 1983 Apr; 77(1):52-68. PubMed ID: 6301697
[TBL] [Abstract][Full Text] [Related]
3. Role of membrane lipids in the immunological killing of tumor cells: II. Effector cell lipids.
Schlager SI; Meltzer MS; Madden LD
Lipids; 1983 Jul; 18(7):483-8. PubMed ID: 6621258
[TBL] [Abstract][Full Text] [Related]
4. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
5. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
6. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
7. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
Leu RW; Rummage JA; Rahimi MB; Herriott MJ
Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
[TBL] [Abstract][Full Text] [Related]
8. Role of C5a in the induction of tumoricidal activity in C3H/HeJ (Lpsd) and C3H/OuJ (Lpsn) macrophages.
Hogan MM; Yancey KB; Vogel SN
J Leukoc Biol; 1989 Dec; 46(6):565-70. PubMed ID: 2509612
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1.
Ralph P; Nakoinz I
Cell Immunol; 1987 Apr; 105(2):270-9. PubMed ID: 2436807
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
Falk LA; Hogan MM; Vogel SN
J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
[TBL] [Abstract][Full Text] [Related]
13. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Ohyama K
Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
[TBL] [Abstract][Full Text] [Related]
14. Effect of L-arginine on the retention of macrophage tumoricidal activity.
Takema M; Inaba K; Uno K; Kakihara K; Tawara K; Muramatsu S
J Immunol; 1991 Mar; 146(6):1928-33. PubMed ID: 2005387
[TBL] [Abstract][Full Text] [Related]
15. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
Ruco LP; Meltzer MS
J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
17. The correlation between specific protein synthesis and tumoricidal function in murine peritoneal macrophages.
Tannenbaum CS; Largen MT
Cell Immunol; 1990 Nov; 131(1):52-66. PubMed ID: 2121374
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
20. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
